Free accessReview articleFirst published online 2007-08
Review Article: Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency: clinical implications of 20 years published experience
Chronic respiratory insufficiency is inevitable in the course of disease progression in patients with Duchenne muscular dystrophy (DMD). Without mechanical ventilation (MV), morbidity and mortality are highly likely towards the end of the second decade of life. The present review reports evidence and clinical implications regarding DMD patients treated with MV. There is no doubt that nocturnal hypercapnia precedes daytime hypercapnia. Historical comparisons have provided evidence that non-invasive intermittent positive pressure ventilation (NIPPV) at night is effective and improves quality of life and survival by 5—10 years. By contrast, the optimal criteria and timing for initiation of NIPPV are inconsistent. A recent randomized study however demonstrated the benefits of commencing NIPPV as soon as nocturnal hypoventilation is detected (Ward S, et al., Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 2005; 60: 1019—24). The respective role of the three hypotheses of the indirect action of nocturnal NIPPV on daytime blood gases may be complimentary; the main improvement may be due to improved ventilatory response to CO2. The ultimate time to offer full time ventilation with the most advantageous interface is lacking in evidence. Full time NIV is possible with a combination of a nasal mask during the night and a mouthpiece during the day, however tracheostomy may be provided when mechanical techniques of cough-assistance are useless to treat chronic cough insufficiency. Chronic Respiratory Disease 2007; 4: 167—177
Rideau Y., Gatin G., Bach J. et al. Prolongation of life in Duchenne's muscular dystrophy. Acta Neurol1983; 5: 118—124.
2.
Phillips MF, Quinlivan RC, Edwards RH et al. Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med2001; 164: 2191—4.
3.
Rideau Y., Jankowski LW, Grellet J.Respiratory function in the muscular dystrophies. Muscle Nerve1981; 4: 155—164.
4.
Baydur A., Gilgoff I., Prentice W. et al. Decline in respiratory function and experience with long-term assisted ventilation in advanced Duchenne's muscular dystrophy. Chest1990; 97: 884—9.
5.
Inkley SR, Oldenburg FC, Vignos PJ Jr.Pulmonary function in Duchenne muscular dystrophy related to stage of disease. Am J Med1974; 56: 297—306.
6.
Phillips MF, Smith PE, Carroll N. et al. Nocturnal oxygenation and prognosis in Duchenne muscular dystrophy . Am J Respir Crit Care Med1999; 160: 198—202.
7.
Ragette R., Mellies U., Schwake C. et al. Patterns and predictors of sleep disordered breathing in primary myopathies. Thorax2002; 57: 724—28.
8.
Hukins CA, Hillman DRDaytime predictors of sleep hypoventilation in Duchenne muscular dystrophy . Am J Respir Crit Care Med2000; 161: 166—170.
9.
Simonds AK, Muntoni F., Heather S. et al. Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax1998; 53: 949—52.
10.
Soudon P., Wouters A., Kulakowski S.pO2-pCO2. Transcutaneous monitoring during sleep and ventilatory function in X-linked progressive muscular dystrophies. Cardiomyology1984; 3: 21—38.
11.
Suresh S., Wales P., Dakin C. et al. Sleep-related breathing disorder in Duchenne muscular dystrophy: disease spectrum in the paediatric population. J Paediatr Child Health2005; 41: 500—3.
12.
Vianello A. , Bevilacqua M., Salvador V. et al. Long-term nasal intermittent positive pressure ventilation in advanced Duchenne's muscular dystrophy. Chest1994; 105: 445—48.
13.
Curran FJNight ventilation by body respirators for patients in chronic respiratory failure due to late stage Duchenne muscular dystrophy. Arch Phys Med Rehabil1981; 62: 270—74.
14.
Mohr CH, Hill NSLong-term follow-up of nocturnal ventilatory assistance in patients with respiratory failure due to Duchenne-type muscular dystrophy. Chest1990; 97: 91—96.
15.
Soudon P., Steens M., Toussaint M. et al. Ventilation assistée au long cours dans les maladies neuro-musculaires . Louvain Med1991; 110: 235—53.
16.
Bach JR, O'Brien J., Krotenberg R., Alba ASManagement of end stage respiratory failure in Duchenne muscular dystrophy . Muscle Nerve1987; 10: 177—182.
17.
Leger P., Bedicam JM, Cornette A. et al. Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chronic respiratory insufficiency. Chest1994; 105: 100—5.
18.
Rideau Y., Delaubier A., Guillou C. et al. Treatment of respiratory insufficiency in Duchenne's muscular dystrophy: nasal ventilation in the initial stages. Monaldi Arch Chest Dis1995; 50: 235—38.
19.
Fanfulla F. , Berardinelli A., Gualtieri G. et al. The efficacy of noninvasive mechanical ventilation on nocturnal hypoxaemia in Duchenne's muscular dystrophy. Monaldi Arch Chest Dis1998; 53: 9—13.
20.
Baydur A., Layne E., Aral H. et al. Long term non-invasive ventilation in the community for patients with musculoskeletal disorders: 46 year experience and review. Thorax2000; 55: 4—11.
21.
Mellies U., Ragette R., Dohna Schwake C et al. Long-term noninvasive ventilation in children and adolescents with neuromuscular disorders. Eur Respir J2003; 22: 631—36.
22.
Ward S., Chatwin M., Heather S. et al. Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax2005; 60: 1019—24.
23.
Anonymous. Consensus conference. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation: a consensus conference report. Chest1999; 116: 521—34.
24.
Coccagna G. , Mantovani M., Parchi C. et al. Alveolar hypoventilation and hypersomnia in myotonic dystrophy. J Neurol Neurosurg Psychiatry1975; 38: 977—84.
25.
Ellis ER, Bye PT, Bruderer JW et al. Treatment of respiratory failure during sleep in patients with neuromuscular disease. Positive-pressure ventilation through a nose mask. Am Rev Respir Dis1987; 135: 148—52.
26.
Smith PE, Calverley PM, Edwards RHHypoxemia during sleep in Duchenne muscular dystrophy. Am Rev Respir Dis1988; 137: 884—88.
27.
Schonhofer B., Geibel M., Sonneborn M. et al. Daytime mechanical ventilation in chronic respiratory insufficiency. Eur Respir J1997 ; 10: 2840—46.
28.
Carroll N., Bain RJ, Smith PE et al. Domiciliary investigation of sleep-related hypoxaemia in Duchenne muscular dystrophy. Eur Respir J1991; 4: 434—40.
29.
Barbe F., Quera-Salva MA, McCann C. et al. Sleep-related respiratory disturbances in patients with Duchenne muscular dystrophy. Eur Respir J1994; 7: 1403—8.
30.
Hess DRNoninvasive ventilation in neuromuscular disease: equipment and application . Respir Care2006; 51: 896—911.
31.
Ragette R., Mellies U., Schwake C. et al. Sleep-disordered breathing in neuromuscular diseases. Pneumologie2003; 57: 729—33.
Bourke SC, Gibson GJSleep and breathing in neuromuscular disease. Eur Respir J2002; 19: 1194—1201.
34.
Lofaso F., Quera-Salva MA. Polysomnography for the management of progressive neuromuscular disorders. Eur Respi J2002; 19: 989—90.
35.
Ramelli GP, Hammer J.Swiss physicians' practices of long-term mechanical ventilatory support of patients with Duchenne Muscular Dystrophy. Swiss Med Wkly2005; 135: 599—604.
36.
Fauroux B., Lofaso F.Non-invasive mechanical ventilation: when to start for what benefit?Thorax2005; 60: 979—80.
37.
Janssens JP , Howarth-Frey C., Chevrolet JC et al. Transcutaneous PCO2 to monitor noninvasive mechanical ventilation in adults: assessment of a new transcutaneous PCO2 device. Chest1998; 133: 768—73.
38.
Senn O., Clarenbach CF, Kaplan V. et al. Monitoring carbon dioxide tension and arterial oxygen saturation by a single earlobe sensor in patients with critical illness or sleep apnea . Chest2005; 128: 1291—96.
39.
Herrejon A. , Inchaurraga I., Palop J. et al. Usefulness of transcutaneous carbon dioxide pressure monitoring to measure blood gases in adults hospitalized for respiratory disease. Arch Bronconeumol2006; 42: 225—29.
40.
Cox M., Kemp R., Anwar S. et al. Non-invasive monitoring of CO2 levels in patients using NIV for AECOPD. Thorax2006; 61: 363—64.
41.
Laub M., Berg S., Midgren B.Symptoms, clinical and physiological findings motivating home mechanical ventilation in patients with neuromuscular diseases. J Rehabil Med2006; 38: 250—54.
42.
Manni R., Zucca C., Galimberti CA et al. Nocturnal sleep and oxygen balance in Duchenne muscular dystrophy. A clinical and polygraphic 2-year follow-up study. Eur Arch Psychiatry Clin Neurosci1991; 240: 255—57.
43.
Lanini B., Misuri G., Gigliotti F. et al. Perception of dyspnea in patients with neuromuscular disease . Chest2001; 120: 402—8.
44.
Hours S., Lejaille M., Pozzi D. et al. Perceived inspiratory difficulty in neuromuscular patients with primary muscle disorders. Neuromuscul Disord2004; 14: 289—96.
45.
Lyager S., Steffensen B., Juhl B.Indicators of need for mechanical ventilation in Duchenne muscular dystrophy and spinal muscular atrophy. Chest1995; 108: 779—85.
46.
Mellies U., Ragette R., Schwake C. et al. Daytime predictors of sleep disordered breathing in children and adolescents with neuromuscular disorders. Neuromuscul Disord2003; 13: 123—8.
47.
Mellies U., Dohna-Schwake C., Ragette R. et al. Nocturnal noninvasive ventilation of children and adolescents with neuromuscular diseases: effects on sleep and symptoms. Wien Klin Wochenschr2003; 115: 855—59.
48.
Toussaint M. , Steens M., Wasteels G. et al. Diurnal ventilation via mouthpiece: survival in end-stage Duchenne patients. Eur Respir J2006; 28: 549—55.
49.
Yasuma F., Kato T., Matsuoka Y. et al. Row-a-boat phenomenon: respiratory compensation in advanced Duchenne muscular dystrophy. Chest2001; 119: 1836—39.
50.
Nicot F., Hart N., Forin V. et al. Respiratory muscle testing: a valuable tool for children with neuromuscular disorders. Am J Respir Crit Care Med2006; 174: 67—74.
51.
Kang SW, Kang YS, Sohn HS et al. Respiratory muscle strength and cough capacity in patients with Duchenne muscular dystrophy. Yonsei Med J2006; 47: 184—190.
52.
Chaudri MB, Liu C., Hubbard R. et al. Relationship between supramaximal flow during cough and mortality in motor neurone disease. Eur Respir J2002 ; 19: 434—38.
53.
Gauld LM, Boynton A.Relationship between peak cough flow and spirometry in Duchenne muscular dystrophy . Pediatr Pulmonol2005; 39: 457—60.
54.
Iandelli I., Gorini M., Misuri G., Gigliotti F., Rosi E., Duranti R., Scano G.Assessing inspiratory muscle strength in patients with neurologic and neuromuscular disease. Chest2001; 119: 1108—13.
55.
Eagle M., Baudouin SV, Chandler C. et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord2002; 12: 926—29.
56.
Canny GJ, Szeinberg A., Koreska J. et al. Hypercapnia in relation to pulmonary function in Duchenne muscular dystrophy. Pediatr Pulmonol1989; 6: 169—171.
57.
Braun NM, Arora NS, Rochester DFRespiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax1983; 38: 616—23.
58.
Yang KLInspiratory pressure/maximal inspiratory pressure ratio: a predictive index of weaning outcome. Intensive Care Med1993 ; 19: 204—8.
59.
Vassilakopoulos T., Zakynthinos S., Roussos C.The tension-time index and the frequency/tidal volume ratio are the major pathophysiologic determinants of weaning failure and success. Am J Respir Crit Care Med1998 ; 158: 378—85.
60.
Koga T., Watanabe K., Sano M. et al. Breathing intolerance index: a new indicator for ventilator use . Am J Phys Med Rehabil2006; 85: 24—30.
61.
Misuri G., Lanini B., Gigliotti F. et al. Mechanism of CO(2) retention in patients with neuromuscular disease. Chest2000; 117: 447—53.
62.
Fanfulla F. , Delmastro M., Berardinelli A. et al. Effects of different ventilator settings on sleep and inspiratory effort in patients with neuromuscular disease. Am J Respir Crit Care Med2005; 172: 619—24.
63.
Matecki S., Topin N., Hayot M. et al. A standardized method for the evaluation of respiratory muscle endurance in patients with Duchenne muscular dystrophy. Neuromuscul Disord2001; 11: 171—77.
64.
Panitch HBRespiratory issues in the management of children with neuromuscular disease . Respir Care2006; 51: 885—93.
65.
Raphael JC, Chevret S., Chastang C. et al. Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. French Multicentre Cooperative Group on Home Mechanical Ventilation Assistance in Duchenne de Boulogne Muscular Dystrophy. Lancet1994; 343: 1600—4.
66.
Howard RS, Davidson C.Long term ventilation in neurogenic respiratory failure. J Neurol Neurosurg Psychiatry2003; 74: 24—30.
Kohler M., Clarenbach CM, Boni L. et al. Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med2005; 172: 1032—36.
69.
Ogata K., Kohno S., Komiya T. et al. Different mechanism may underlie respiratory failure of myotonic and Duchenne muscular dystrophies: a pulseoxymetric and spirometric study . Rinsho Shinkeigaku1996; 36: 850—53.
70.
Robert D., Willig TN, Leger P. et al. Long-term nasal ventilation in neuromuscular disorders: report of a consensus conference. Eur Respir J1993 ; 6: 599—606.
71.
Hahn A., Bach JR, Delaubier A. et al. Clinical implications of maximal respiratory pressure determinations for individuals with Duchenne muscular dystrophy. Arch Phys Med Rehabil1997; 78: 1—6.
72.
Servera E., Sancho J., Zafra MJ et al. Alternatives to endotracheal intubation for patients with neuromuscular diseases. Am J Phys Med Rehabil2005; 84: 851—57.
73.
Tzeng AC, Bach JRPrevention of pulmonary morbidity for patients with neuromuscular disease . Chest2000; 118: 1390—96.
74.
Gomez-Merino E., Bach JRDuchenne muscular dystrophy: prolongation of life by noninvasive ventilation and mechanically assisted coughing. Am J Phys Med Rehabil2002; 81: 411—15.
75.
Benditt JOFull-time noninvasive ventilation: possible and desirable. Respir Care2006; 51: 1005—12.
76.
Hill NSNeuromuscular disease in respiratory and critical care medicine. Respir Care2006; 51: 1065—71.
77.
Leger P., Paulus J. Summary: Recommendations of HAS: Practical issues in home non-invasive ventilation in patients with neuromuscular disease. Rev Mal Respir Suppl 2006; 23: S141—43.
78.
Parker AE, Robb SA, Chambers J. et al. Analysis of an adult Duchenne muscular dystrophy population . QJM2005; 98: 729—36.
79.
Schonhofer B., Sonneborn M., Haidl P. et al. Comparison of two different modes for noninvasive mechanical ventilation in chronic respiratory failure: volume versus pressure controlled device. Eur Respir J1997; 10: 184—191.
80.
Chadda K., Clair B., Orlikowski D. et al. Pressure support versus assisted controlled noninvasive ventilation in neuromuscular disease. Neurocrit Care2004 ; 1: 429—34.
81.
Kreit JW, Capper MW, Eschenbacher WLPatient work of breathing during pressure support and volume-cycled mechanical ventilation. Am J Respir Crit Care Med1994 ; 149: 1085—91.
82.
Girault C., Richard JC, Chevron V. et al. Comparative physiologic effects of noninvasive assist-control and pressure support ventilation in acute hypercapnic respiratory failure . Chest1997; 111: 1639—48.
83.
Branson RD, Davis K. Jr.Dual control modes: combining volume and pressure breaths. Respir Care Clin N Am2001; 7: 397—408.
84.
Keszler M.Volume-targeted ventilation. Early Hum Dev2006; 82: 811—18.
85.
Storre JH, Seuthe B., Fiechter R. et al. Average volume-assured pressure support in obesity hypoventilation: A randomized crossover trial. Chest2006; 130: 815—21.
86.
Nava S., Ceriana P.Patient-ventilator interaction during noninvasive positive pressure ventilation . Respir Care Clin N Am2005; 11: 281—93.
Meyer TJ, Pressman MR, Benditt J. et al. Air leaking through the mouth during nocturnal nasal ventilation: effects on sleep quality. Sleep1997; 20: 561—69.
89.
Guilleminault C., Philip P., Robinson A.Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease. J Neurol Neurosurg Psychiatry1998; 65: 225—32.
90.
Boitano LJ, Benditt JOAn evaluation of home volume ventilators that support open-circuit mouthpiece ventilation. Respir Care2005; 50: 1457—61.
91.
Bach JR, Alba AS, Saporito LRIntermittent positive pressure ventilation via de mouth as an alternative to tracheostomy for 257 ventilator users. Chest1993; 103: 174—182.
92.
Parreira VF , Jounieaux V., Aubert G. et al. Nasal two-level positive-pressure ventilation in normal subjects. Effects of the glottis and ventilation. Am J Respir Crit Care Med1996; 153: 1616—23.
93.
Baydur A., Kanel G.Tracheobronchomalacia and tracheal hemorrhage in patients with Duchenne muscular dystrophy receiving long-term ventilation with uncuffed tracheostomies. Chest2003; 123: 1307—11.
94.
Parreira VF , Jounieaux V., Delguste P. et al. Determinants of effective ventilation during nasal intermittent positive pressure ventilation. Eur Respir J1997; 10: 1975—82.
95.
Leger P., Jennequin J., Gerard M. et al. Home positive pressure ventilation via nasal mask for patients with neuromuscular weakness or restrictive lung or chest-wall disease. Respir Care1989; 34: 73—77.
96.
Piper AJ, Sullivan CEEffects of long-term nocturnal nasal ventilation on spontaneous breathing during sleep in neuromuscular and chest wall disorders. Eur Respir J1996; 9: 1515—22.
97.
Barbe F., Quera-Salva MA, de Lattre J. et al. Long-term effects of nasal intermittent positive-pressure ventilation on pulmonary function and sleep architecture in patients with neuromuscular diseases. Chest1996; 110: 1179—83.
98.
Janssens JP , Derivaz S., Breitenstein E. et al. Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area. Chest2003; 123: 67—79.
99.
Chailleux E. , Fauroux B., Binet F. et al. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. Chest1996 ; 109: 741—19.
100.
Lofaso F., Orlikowski D., Raphael J-C.Ventilatory assistance in patients with Duchenne muscular dystrophy. Eur Respir J2006; 28: 468—69.
101.
Soudon P.Mechanical ventilation by tracheostomy in neuromuscular diseases: experience and evaluation. Eur Respir Rev1993; 3: 300—4.
102.
Gatin G.The value of assisted ventilation in muscular dystrophies. Ann Med Phys1983; 26: 111—28.
103.
Shneerson JM, Simonds AKNoninvasive ventilation for chest wall and neuromuscular disorders. Eur Respir J2002 ; 20: 480—87.
104.
Brooks D., King A., Tonack M. et al. User perspectives on issues that influence the quality of daily life of ventilator-assisted individuals with neuromuscular disorders. Can Respir J2004; 11: 547—54.
105.
Dellborg C., Olofson J., Midgren B. et al. Quality of life in patients with chronic alveolar hypoventilation . Eur Respir J2002; 19: 113—20.
106.
Goldstein RS, Psek JA, Gort EHHome mechanical ventilation. Demographics and user perspectives. Chest1995; 108: 1581—16.
107.
Annane D., Chevrolet JC, Chevret S. et al. Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders. Cochrane Database Syst Rev2000; CD001941.
108.
Konagaya M., Sakai M., Wakayama T. et al. Effect of intermittent positive pressure ventilation on life-span and causes of death in Duchenne muscular dystrophy. Rinsho Shinkeigaku2005; 45: 643—46.
109.
Yasuma F., Sakai M., Matsuoka Y.Effects of noninvasive ventilation on survival in patients with Duchenne's muscular dystrophy. Chest1996; 109: 590.
110.
Jeppesen J. , Green A., Steffensen BF et al. The Duchenne muscular dystrophy population in Denmark, 1977—2001: prevalence, incidence and survival in relation to the introduction of ventilator use. Neuromuscul Disord2003; 13: 804—12.
111.
Gibson B.Long-term ventilation for patients with Duchenne muscular dystrophy: physician's beliefs and practices. Chest2001; 119: 940—46.
112.
Simonds AKLiving ad dying with respiratory failure: facilitating decision making. ChronRespir Dis2004; 1: 56—59.
113.
Hill NSNoninvasive ventilation. Does it work, for whom, and how?Am Rev Respir Dis1993; 147: 1050—5.
114.
Carrey Z., Gottfried SB, Levy RDVentilatory muscle support in respiratory failure with nasal positive pressure ventilation. Chest1990; 97: 150—58.
115.
Vassilakopoulos T., Zakynthinos S., Roussos C.Bench-to-bedside review: Weaning failure: should we rest the respiratory muscles with controlled mechanical ventilation?Crit Care2006; 10: 204.
116.
McCool FD, Mayewski RF, Shayne DS et al. Intermittent positive pressure breathing in patients with respiratory muscle weakness. Alterations in total respiratory system compliance. Chest1986; 90: 546—52.
117.
De Troyer A, Deisser P.The effects of intermittent positive pressure breathing on patients with respiratory muscle weakness. Am Rev Respir Dis1981; 124: 132—27.
118.
Turkington PM, Elliott MWRationale for the use of non-invasive ventilation in chronic ventilatory failure. Thorax2000 ; 55: 417—23.
119.
Meyer TJ, Hill NSNoninvasive positive pressure ventilation to treat respiratory failure. Ann Intern Med1994; 120: 760—70.
120.
Goldstein RS, Molotiu N., Skrastins R. et al. Reversal of sleep-induced hypoventilation and chronic respiratory failure by nocturnal negative pressure ventilation in patients with restrictive ventilatory impairment. Am Rev Respir Dis1987; 135: 1049—55.
121.
Annane D., Quera-salva MA, Lofaso F. et al. Mechanisms underlying effects of nocturnal ventilation on daytime blood gases in neuromuscular diseases. Eur Respir J1999; 13: 157—62.
122.
Dellborg C. , Olofson J., Hamnegard CH et al. Ventilatory response to CO2 re-breathing before and after nocturnal nasal intermittent positive pressure ventilation in patients with chronic alveolar hypoventilation. Respir Med2000; 94: 1154—60.
123.
Nickol AH, Hart N., Hopkinson NS et al. Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation. Thorax2005; 60: 754—60.
124.
Ergun P., Aydin G., Turay UY et al. Short-term effect of nasal intermittent positive-pressure ventilation in patients with restrictive thoracic disease. Respiration2002; 69: 303—8.
125.
Diaz O., Begin P., Andresen M. et al. Physiological and clinical effects of diurnal noninvasive ventilation in hypercapnic COPD. Eur Respir J2005; 26: 1016—23.
126.
Leger P., Langevin B., Guez A. et al. What to do when nasal ventilation fails for neuromuscular patients . Eur Respir Rev1993; 3: 279—83.
127.
Teschler H. , Stampa J., Ragette R. et al. Effects of mouth leak on effectiveness of nasal bilevel ventilatory assistance and sleep architecture. Eur Respir J1999; 14: 1251—57.
128.
Gonzales J. , Sharshar T., Hart N. et al. Air leaks during mechanical ventilation as a cause of persistent hypercapnia in neuromuscular disorders. Intensive Care Med2003; 29: 596—602.
129.
Parreira VF , Delguste P., Jounieaux V. et al. Effectiveness of controlled and spontaneous modes in nasal two-level positive pressure ventilation in awake and asleep normal subjects. Chest1997; 112: 1267—77.
130.
Leger P.Long-term ventilation in restrictive ventilatory disorders. Respir Care Clin N Am2002; 8: 507—32.
131.
Windisch W. , Dreher M., Storre JH et al. Nocturnal non-invasive positive pressure ventilation: physiological effects on spontaneous breathing. Respir Physiol Neurobiol2006; 150: 251—60.
132.
Katz S., Selvadurai H., Keilty K. et al. Outcome of non-invasive positive pressure ventilation in paediatric neuromuscular disease. Arch Dis Child2004 ; 89: 121—24.
133.
Finder JD, Birnkrant D., Carl J. et al. American Thoracic Society. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Care Med2004; 170: 456—65.
